BridgeBio Pharma Inc
General ticker "BBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.1B
BridgeBio Pharma Inc does not follow the US Stock Market performance with the rate: -19.0%.
Estimated limits based on current volatility of 3.0%: low 25.63$, high 27.23$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [18.54$, 48.10$]
- 2024-12-30 to 2025-12-30 estimated range: [12.68$, 34.80$]
Financial Metrics affecting the BBIO estimates:
- Negative: Non-GAAP EPS, $ of -3.94 <= 0.10
- Negative: Operating profit margin, % of -98.49 <= 1.03
- Negative: Operating cash flow per share per price, % of -8.59 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term BBIO quotes
Long-term BBIO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $69.72MM | $77.65MM | $9.30MM |
| Operating Expenses | $646.35MM | $589.85MM | $616.67MM |
| Operating Income | $-576.63MM | $-512.20MM | $-607.37MM |
| Non-Operating Income | $-9.82MM | $27.55MM | $-45.88MM |
| Interest Expense | $46.78MM | $80.44MM | $81.29MM |
| R&D Expense | $454.14MM | $402.90MM | $455.71MM |
| Income(Loss) | $-586.45MM | $-484.65MM | $-653.25MM |
| Taxes | $0.00MM | $0.00MM | $-10.05MM |
| Profit(Loss) | $-586.45MM | $-484.65MM | $-643.20MM |
| Stockholders Equity | $-870.41MM | $-1,254.62MM | $-1,354.26MM |
| Inventory | $68.90MM | $37.93MM | $0.00MM |
| Assets | $1,012.79MM | $623.04MM | $546.38MM |
| Operating Cash Flow | $-497.93MM | $-419.49MM | $-527.72MM |
| Capital expenditure | $48.25MM | $6.32MM | $1.31MM |
| Investing Cash Flow | $-200.83MM | $453.15MM | $54.03MM |
| Financing Cash Flow | $736.45MM | $-13.13MM | $451.54MM |
| Earnings Per Share* | $-4.43 | $-3.35 | $-3.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.